Levofloxacin (Levaquin) Infiltration Management
Levofloxacin infiltration does not require specialized care beyond standard IV infiltration management protocols. The drug is not classified as a vesicant or irritant requiring specific antidotes or interventions.
Standard Infiltration Care Approach
When levofloxacin infiltrates, implement these immediate steps:
- Stop the infusion immediately upon recognition of infiltration
- Disconnect the IV line but leave the catheter in place initially
- Aspirate any residual drug from the catheter if possible
- Remove the catheter after attempting aspiration
- Elevate the affected extremity above heart level to reduce swelling
- Apply warm or cool compresses based on patient comfort (no specific temperature requirement for levofloxacin)
- Assess and document the extent of infiltration including volume, appearance, and patient symptoms
- Monitor the site for 24-48 hours for signs of tissue damage, though this is rare with levofloxacin
Why Levofloxacin Is Low-Risk for Infiltration
The FDA drug label 1 indicates levofloxacin has excellent tissue penetration properties and distributes widely into body tissues with a volume of distribution of 74-112 L. The drug reaches high concentrations in skin tissues (skin tissue to plasma AUC ratio approximately 2:1) 1. This pharmacokinetic profile suggests the drug is well-tolerated by tissues even with inadvertent extravasation.
Levofloxacin is pH-neutral and non-vesicant, meaning it does not cause tissue necrosis or require antidote administration like chemotherapeutic agents or certain other medications.
Clinical Monitoring
After managing the infiltration:
- Observe for local reactions: mild erythema, swelling, or discomfort typically resolve within 24-48 hours
- No specific laboratory monitoring is required for infiltration events
- Document the incident per institutional policy
- Restart IV access at a different site if continued therapy is needed
When to Escalate Care
Seek additional consultation if:
- Severe pain persists beyond 24 hours
- Progressive swelling or skin changes develop
- Signs of compartment syndrome appear (though extremely rare)
- Skin breakdown or blistering occurs
Continuing Therapy
Switch to oral levofloxacin if IV access is problematic, as the oral formulation has approximately 99% bioavailability and is bioequivalent to IV administration 1. The oral and IV routes are completely interchangeable without dose adjustment, making this an excellent option to avoid further IV complications.
The key principle is that levofloxacin infiltration is managed like any non-vesicant IV infiltration—with supportive care and monitoring rather than specialized interventions.